Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients
- 1 October 2011
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 7 (6), 730-737
- https://doi.org/10.4244/eijv7i6a116
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 17 references indexed in Scilit:
- Treatment of small coronary arteries with a paclitaxel-coated balloon catheterClinical Research in Cardiology, 2010
- Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent RestenosisCirculation, 2009
- Paclitaxel‐eluting balloon: From bench to bedCatheterization and Cardiovascular Interventions, 2008
- Inhibition of Restenosis in Femoropopliteal ArteriesCirculation, 2008
- Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the LegNew England Journal of Medicine, 2008
- Drug-Eluting Stent Update 2007Circulation, 2007
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterNew England Journal of Medicine, 2006
- Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent RestenosisJAMA, 2005
- Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of RestenosisCirculation, 2004
- Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug DeliveryCirculation, 1997